IMUX Immunic: Forvard P/S multiplikatori
GURU.Markets platformasida forward P/S tendentsiyasini tahlil qilish kichik molekulyar patentlar Immunic, Inc. (IMUX) pozitsiyalarini inyeksiyali dori vositalaridan qanday himoya qilishini ochib beradi. Psoriaz va skleroz terapiyasi uchun tabletkalarning qulayligi biznes kengayishini tezlashtiradi, esa parametrning joriy holatini belgilaydi. 2-fazali sinov natijalarining kutilishi kompaniyaning qiymati o'sishi uchun kuchli drayver vazifasini o'taydi.
immunic-therapeutics.com (IMUX) kompaniyasi koʻrsatkichlari kesimi va tahlili
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
- emitentning balans qiymati statistikasi:
- kompaniyaning majburiyatlari va likvidligi ma'lumotlari:
Umumiy qarzning xususiy kapitalga nisbati Immunic, Inc.|IMUX - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Immunic|IMUX - Kompaniyaning jamlangan qarzi|Balans kapitallashuviga qarzlar IMUX|IMUX - Uzoq muddatli qarz hajmi|Kompaniyaning qisqa muddatli qarzlari Immunic|Tezkor likvidlik ko‘rsatkichi immunic-therapeutics.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
IMUX - Yakuniy foyda|Prognoz qilingan kelajakdagi foyda Immunic, Inc.|IMUX - Biznesning o‘zini qoplash muddati|Kelajakdagi narxning foydaga nisbati Immunic|IMUX - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|EV/EBITDA multiplikatori IMUX|IMUX - Eskirish chegirilmasdan oldingi operatsion foyda|So'nggi 12 oy davomida bir aksiya uchun sof foyda Immunic|IMUX - So'nggi to'rtta chorak uchun bir aksiya uchun sof foyda|Choraklik EPS foyda o'sishi immunic-therapeutics.com|IMUX - Bu yil bir aksiya uchun sof foydaning kutilayotgan o'sishi|Keyingi yil uchun bir aksiya uchun sof foyda o'sishi prognozi Immunic, Inc.
- sotuvlar va tushum bo'yicha ma'lumotlar:
Kompaniyaning fundamental baholanishi:Immunic Inc IMUX
Immunic, Inc. (IMUX) uchun forward P/S ko'rsatkichi immunologik ishlanmalarning kelgusidagi monetizatsiyasiga bo'lgan bozor kutuvlarini aks ettirib, joriy kapitalizatsiyani prognoz qilingan savdo hajmi bilan bog'laydi. Forward P/S baholashining ushbu tendentsiyasi konsensus daromad prognozlarining kunlik qayta hisob-kitoblariga asoslangan bo'lib, bunda dori vositalarini chiqarish bo'yicha shartnomaviy ishlab chiqarish quvvatlarining yuqori tayyorgarligi hisobga olinadi, bu esa investorlarga aktivning o'z potentsialiga nisbatan haddan tashqari sotib olinganlik darajasini zudlik bilan baholash imkonini beradi.
Raqobatdosh kompaniyalar tahlili
Forvard P/S multiplikatori ARGX (argenx)|BioNTech Inc. (BNTX) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Abivax Corp - Forvard P/S multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati ADMA Corp ADMA|Protagonist Therapeutics (PTGX) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori immunovant.com|Narxning prognoz qilingan daromadga nisbati Kiniksa|Forvard narx/daromad multiplikatori Grifols SA (GRFS)|Forvard narx/daromad multiplikatori ADPT (Adaptive Biotechnologies Corp)|Forvard P/S multiplikatori Celldex Corp (CLDX)|Narxning prognoz qilingan daromadga nisbati Aurinia Pharmaceuticals AUPH|BCRX: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Vera Therapeutics - Forvard P/S multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Dianthus Therapeutics Inc DNTH|PHVS: Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori AbCellera Corp|Forvard narx/daromad multiplikatori TRML|PGEN: Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori PHAR|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Nektar Therapeutics Inc|Narxning prognoz qilingan daromadga nisbati Upstream Bio Corp UPB|ZBIO: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Immunome, Inc. - Forvard P/S multiplikatori|gossamerbio.com (GOSS) - Forvard narx/daromad multiplikatori|KALV (KalVista Pharmaceuticals, Inc.) - Forvard narx/daromad multiplikatori|SEPN - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|PVLA (Pieris Pharmaceuticals Inc) - Forvard P/S multiplikatori|Savara Pharma (SVRA) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati Rigel Pharmaceuticals (RIGL)|Forvard narx/daromad multiplikatori anaptysbio.com ANAB|Astria Therapeutics, Inc. - Forvard narx/daromad multiplikatori|Forvard P/S multiplikatori enGene Holdings Inc ENGN|RAPT: Forvard narx/daromad multiplikatori|JBIO (Aerovate Therapeutics Inc) - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Aclaris Therapeutics (ACRS) - Narxning prognoz qilingan daromadga nisbati|Kelajakdagi narxning daromadga nisbati KYTX (kyvernatx.com)|TLSA (Tiziana Life Sciences Ltd) - Forvard P/S multiplikatori|CABA: Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori VTYX|Forvard P/S multiplikatori Theratechnologies, Inc (THTX)|Narxning prognoz qilingan daromadga nisbati Avalo Therapeutics, Inc AVTX|Sotuvga nisbatan forvard narx ELDN|AGEN - Narxning prognoz qilingan daromadga nisbati|Climb Bio Inc. (CLYM) - Forvard narx/daromad multiplikatori|ZURA: Forvard P/S multiplikatori|aTyr Pharmaceuticals (ATYR) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori ADAG|IMA: Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori STTK|Kapitalizatsiyaning kutilayotgan sotuvga nisbati equilliumbio.com|Narxning prognoz qilingan daromadga nisbati Connect Biopharma Holdings Limited CNTB|ATRA - Forvard narx/daromad multiplikatori|IFRX - Narxning prognoz qilingan daromadga nisbati|x4pharma.com (XFOR) - Forvard narx/daromad multiplikatori|ACET (adicetbio.com) - Forvard narx/daromad multiplikatori|Celularity (CELU) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati INmune Bio Corp|Kapitalizatsiyaning prognoz qilingan daromadga nisbati BRNS (Barinthus Biotherapeutics Corp)|Forvard P/S multiplikatori KZR|SABS - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Forvard P/S multiplikatori AKTX (Akari Therapeutics Plc)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Enlivex Therapeutics Ltd (ENLV)|QTTB - Narxning prognoz qilingan daromadga nisbati|GeoVax Corp (GOVX) - Forvard narx/daromad multiplikatori|Edesa Biotech, Inc. (EDSA) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori ibioinc.com|Forvard narx/daromad multiplikatori CARM|Forvard P/S multiplikatori XTL Biopharmaceuticals Ltd|Narxning prognoz qilingan daromadga nisbati Bolt Biotherapeutics (BOLT)|hcwbiologics.com - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Forvard P/S multiplikatori APVO (Aptevo Therapeutics Inc.)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati AIM ImmunoTech, Inc. (AIM)|Aditxt Corp - Forvard P/S multiplikatori|GRI Bio Inc (GRI) - Forvard narx/daromad multiplikatori|XRTX (XORTX) - Forvard narx/daromad multiplikatori|Vyome Therapeutics - Sotuvga nisbatan forvard narx|REVB (Revelation Biosciences) - Forvard P/S multiplikatori|indaptusrx.com (INDP) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati Scinai Immunotherapeutics Ltd. (SCNI)|calcimedica.com - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Forvard P/S multiplikatori AFMD (Affimed N.V.)|ALLK - Forvard narx/daromad multiplikatori|HOOK: Forvard narx/daromad multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati IGM Biosciences, Inc. IGMS|ITOS: Forvard P/S multiplikatori|OCEA - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati TC BioPharm (Holdings) PLC|Forvard narx/daromad multiplikatori Third Harmonic Bio Inc (THRD)
